2/28/2013

The infusion of T cells programmed to detect a tumor antigen and exposed to interleukin 21 appeared to extend survival for patients with recurrent leukemia who had received stem cell transplants. The results of the small study were published in the journal Science Translational Medicine.

Full Story:
DailyRx.com

Related Summaries